We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go: Extended investment: Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go: TBC investment: £127,001
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go: Extended investment: £295,000
Celestial Labs is a drone display company that combines advanced technology with organic performance. The company's proprietary 'Skytheatre' display is a dynamic, safe and green alternative to carbon-intensive fireworks and represents a new frontier for the live event industry. Composed of a creative collective of award-winning filmmakers, musicians, developers, entrepreneurs, and storytellers, the company is constantly pushing the boundaries of drone display innovation, where technology meets imagination. The Human Support division of Celestial is a not-for-profit initiative that aims to lift the spirits of those who witness Celestial's displays whilst imparting crucial information. The company aims to enlist the support and guidance of city leadership partners, industrial conglomerates, and seek grant funding.
days to go: Stretch investment: Withheld
Stroli – the shopping trolley reimagined for modern needs. The shopping trolley, often associated with a particular image, is an untapped category ready for innovation. The market is flooded with generic, budget-friendly options that lack charm, with the exception of Rolser, which is pricier and claims the green niche. Stroli steps in as the go-to brand, offering a unique approach, positioning, voice, and eco-friendly credentials. Say goodbye to sore hands and plastic bags – Stroli makes shopping a pleasure with its high-quality, stylish trolley bags designed to enhance your convenience and style
days to go: Extended investment: Withheld
Yolk, also known as In One Basket Limited, is a pioneering company revolutionizing the food and coffee experience for people on the move. They provide high-quality sandwiches, salads, and improved breakfast options without the premium cost, boasting five successful locations in London and three upcoming openings in the second half of 2023
days to go: TBC investment: Withheld
A subscription service for coffee and coffee accessories from the UK's best roasters. The Coffee Tasting Club wants its customers to experience a different coffee day after day, to discover new tastes and experiment with unique flavours. The company already has a successful infrastructure in place and is ready to go worldwide with the brand.
days to go: Expired investment: £63,815
gowithYamo aims to make art more accessible to everyone, from art newbies to experienced gallery-goers through its application. Users can collect Yamo points by checking-in to galleries and exchanging them for rewards such as art prints and exhibition tickets from the company's in-app store. gowithYamo provides support to galleries, museums and artists by exposing them to an active community of art lovers. The company also offers custom-built virtual exhibition spaces where artists can show and sell their work to a sizeable digital audience. gowithYamo has collaborated with art entities like Roy's Art Fair, The Other Art Fair, Harlesden High Street, and many others. It has a social media presence of 50,000+ followers. The company will use 30% of the investment to expand across different demographics, 25% to further finetune its virtual exhibition platform, 20% for marketing, and 25% to implement Artificial Intelligence (AI) in the gowithYamo app to help recommend exhibitions to its users.

Pitch Rated

52%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: £161,105
Specilaing in making a wide variety of award-winning pies and pastry products for the public. Eat Square's 2017 funding round has resulted in their turnover more than doubling in 2018. This growth has led to Eat Square expanding their business and begin to sell franchises to market their goods. Production and capacity have also increased and products that are vegan and gluten-free are being produced. This funding round will see the business sell up to 14 franchises by the end of 2019 to buy their pies.
days to go: Expired investment: £34,019
Nourish by Jane Clarke (NBJC) is an aspirational wellness brand that makes nutritious drinks made with all-natural organic ingredients, using low carbon footprint packaging, delivered to a customer's doorstep. Its target audience is people afflicted with malnutrition particularly when undergoing cancer treatment or living with dementia or mental illness. The company expanded its customer base by 789% between January 2020 and March 2021. It also points out that it has onboarded noted Chef Prue Leith. The company has featured in numerous publications like Daily Mail, Net Doctor, The Sun Online, and Daily Express, to name a few. NBJC has raised more than £650,000 from private investors in its previous round and secured an 'Excellent' rating of 4.7 on Trustpilot from 100+ verified reviews. It also seeks to become a contender in the Oral Nutritional Supplement (ONS) market in the UK that is valued at £237 million. The company will use the investment to launch and scale its B2B model and invest in Direct-to-Consumer (DTC) marketing.

Pitch Rated

72%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £257,579
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph